SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Eptifibatide for Injection in the ...

Avenacy, a specialty pharmaceutical company that supplies injectable medications, launched Eptifibatide for Injection, a generic for Merck’s Integrilin. Eptifibatide for Injection is indicated for use ...

Baxter announced the availability of ready-to-use Eptifibatide Injection in a flexible container. Baxter announced the availability of ready-to-use Eptifibatide Injection in a flexible container.

An international study to resolve a decade of debate over the best timing for administering an anti-clotting drug for certain heart patients has come up with an answer: It doesn't matter. According to ...

Providing a shorter infusion of the glycoprotein IIb/IIIa inhibitor (GPI) eptifibatide to patients undergoing PCI cuts costs and does not worsen outcomes, according to a single-center study published ...

Teva announced the availability of a new 20mg/10mL (2mg/mL) strength of Eptifibatide Injection, the generic version of Merck's Integrilin. Integrilin is a GP IIb/IIIa blocker indicated for acute ...

Patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) treated with percutaneous coronary intervention (PCI) benefit from early treatment with eptifibatide, according to a substudy ...

An international study to resolve a decade of debate over the best timing for administering an anti-clotting drug for certain heart patients has come up with an answer: It doesn't matter. An ...

Cleveland, OH - A subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) study suggests that the heparin plus IIb/IIIa blocker strategy has a ...

Anthony A. Bavry, M.D., M.P.H.; Deepak L. Bhatt, M.D., F.A.C.C. Patients with stable and unstable coronary artery disease undergoing stenting were eligible for study ...

Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide (an ...